CR Bard (BCR) Q1 2012 Earnings Call April 24, 2012 5:00 pm ET Executives Timothy M. Ring - Chairman, Chief Executive Officer and Chairman of Executive Committee John H. Weiland - President, Chief Operating Officer and Director Todd C. Schermerhorn - Chief Financial Officer and Senior Vice President John A. DeFord - Senior Vice President of Science Technology & Clinical Affairs Analysts Jonathan J. Palmer - Credit Agricole Securities (USA) Inc., Research Division Michael Matson - Mizuho Securities USA Inc., Research Division Michael N. Weinstein - JP Morgan Chase & Co, Research Division Frederick A. Wise - Leerink Swann LLC, Research Division Matthew J. Dodds - Citigroup Inc, Research Division Jason Wittes - Caris & Company, Inc., Research Division David R. Lewis - Morgan Stanley, Research Division Topher Orr - Goldman Sachs Group Inc., Research Division Kristen M. Stewart - Deutsche Bank AG, Research Division Matthew O'Brien - William Blair & Company L.L.C., Research Division Lennox Ketner - BofA Merrill Lynch, Research Division Daniel Sollof - Barclays Capital, Research Division Joshua T. Jennings - Cowen and Company, LLC, Research Division Anthony Petrone - Jefferies & Company, Inc., Research Division Robert M. Goldman - CL King & Associates, Inc. PresentationOperator
Ladies and gentlemen, thank you for standing by. Welcome to the C. R. Bard, Inc. First Quarter 2012 Earnings Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded and will be available for future on-demand replay through Bard's website. Today's presentation will be hosted by Timothy M. Ring, Chairman and Chief Executive Officer; along with Jay H. Weiland, President and Chief Operating Officer; Todd C. Schermerhorn, Senior Vice President and Chief Financial Officer; and John A. DeFord, Senior Vice President, Science Technology and Clinical Affairs. Also in attendance today is Todd W. Garner, Vice President, Investor Relations. Today, Bard's management will discuss some forward-looking statements, the accuracy of which are necessarily subject to risks and uncertainties. Please refer to the cautionary statement regarding forward-looking information and the information under the caption Risk Factors, each in Bard's 2011 10-K, including disclosures of factors that could cause actual results to differ materially from those expressed or implied.